Literature DB >> 2985903

Binding and processing of epidermal growth factor in Panc-I human pancreatic carcinoma cells.

M Korc, B E Magun.   

Abstract

The binding of 125I-labeled epidermal growth factor (EGF) was studied in Panc-I human pancreatic carcinoma cells. At 37 degrees C, binding was rapid and associated with marked endocytosis of the ligand. Bound EGF was sequentially converted to a number of more acidic species as follows: pI 4.55 to pI 4.2, to pI 4.35, to pI 4.0. EGF internalization and processing were blocked at 4 degrees C. EGF did not alter cell growth when Panc-I cells were incubated in the presence of 2 to 10% serum. In contrast, when the serum concentration was lowered to 0.1%, EGF significantly enhanced cell replication after 6 days of culture.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985903     DOI: 10.1016/0024-3205(85)90158-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

Review 1.  Potential role of the epidermal growth factor receptor in human pancreatic cancer.

Authors:  M Korc
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

2.  Recycling of epidermal growth factor in a human pancreatic carcinoma cell line.

Authors:  M Korc; B E Magun
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

3.  The inhibitory effect of an EGF receptor-specific tyrosine kinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptors for EGF and IGF I.

Authors:  M Kobari; B Kullenberg; A Björkman; S Matsuno; I Ihse; J Axelson
Journal:  Int J Pancreatol       Date:  1998-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.